2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine

C106H68N8 — CID 158005802

IUPAC2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine
SMILESc1ccc(-c2ccc3c(c2)c2cc(-c4ccc5c(c4)c4ccccc4n5-c4nc(-c5ccccc5)c5c(n4)-c4ccccc4C5)ccc2n3-c2ccccc2)cc1.c1ccc(-c2ccc3c(c2)c2cc(-c4ccc5c(c4)c4ccccc4n5-c4nc(-c5ccccc5)nc5c4Cc4ccccc4-5)ccc2n3-c2ccccc2)cc1
InChIInChI=1S/2C53H34N4/c1-4-14-34(15-5-1)36-24-27-48-44(30-36)45-32-38(25-28-49(45)56(48)40-19-8-3-9-20-40)37-26-29-50-43(31-37)42-22-12-13-23-47(42)57(50)53-46-33-39-18-10-11-21-41(39)51(46)54-52(55-53)35-16-6-2-7-17-35;1-4-14-34(15-5-1)36-24-27-48-44(30-36)45-32-38(25-28-49(45)56(48)40-19-8-3-9-20-40)37-26-29-50-43(31-37)42-22-12-13-23-47(42)57(50)53-54-51(35-16-6-2-7-17-35)46-33-39-18-10-11-21-41(39)52(46)55-53/h2*1-32H,33H2
InChIKeyFEGUQLTXZQCHEO-UHFFFAOYSA-N
MW1453.77 g/mol
LogP26.49
Rot. Bonds10

About 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine

2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine (PubChem CID 158005802) has the molecular formula C106H68N8 and a molecular weight of 1453.77 g/mol. Its IUPAC name is 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine.

Molecular Properties

Compound Name2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine
PubChem CID158005802
Molecular FormulaC106H68N8
Molecular Weight1453.77 g/mol
Exact Mass1452.56
IUPAC Name2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine
SMILESc1ccc(-c2ccc3c(c2)c2cc(-c4ccc5c(c4)c4ccccc4n5-c4nc(-c5ccccc5)c5c(n4)-c4ccccc4C5)ccc2n3-c2ccccc2)cc1.c1ccc(-c2ccc3c(c2)c2cc(-c4ccc5c(c4)c4ccccc4n5-c4nc(-c5ccccc5)nc5c4Cc4ccccc4-5)ccc2n3-c2ccccc2)cc1
InChIInChI=1S/2C53H34N4/c1-4-14-34(15-5-1)36-24-27-48-44(30-36)45-32-38(25-28-49(45)56(48)40-19-8-3-9-20-40)37-26-29-50-43(31-37)42-22-12-13-23-47(42)57(50)53-46-33-39-18-10-11-21-41(39)51(46)54-52(55-53)35-16-6-2-7-17-35;1-4-14-34(15-5-1)36-24-27-48-44(30-36)45-32-38(25-28-49(45)56(48)40-19-8-3-9-20-40)37-26-29-50-43(31-37)42-22-12-13-23-47(42)57(50)53-54-51(35-16-6-2-7-17-35)46-33-39-18-10-11-21-41(39)52(46)55-53/h2*1-32H,33H2
InChIKeyFEGUQLTXZQCHEO-UHFFFAOYSA-N
XLogP26.49
TPSA71.28 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds10
Heavy Atoms114
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001453.77
LogP ≤ 526.49
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine?
The IUPAC name of 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine (CID 158005802) is 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine.
What is the SMILES notation for 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine?
The canonical SMILES for 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine is c1ccc(-c2ccc3c(c2)c2cc(-c4ccc5c(c4)c4ccccc4n5-c4nc(-c5ccccc5)c5c(n4)-c4ccccc4C5)ccc2n3-c2ccccc2)cc1.c1ccc(-c2ccc3c(c2)c2cc(-c4ccc5c(c4)c4ccccc4n5-c4nc(-c5ccccc5)nc5c4Cc4ccccc4-5)ccc2n3-c2ccccc2)cc1.
What is the InChIKey of 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine?
The InChIKey is FEGUQLTXZQCHEO-UHFFFAOYSA-N. The full InChI is InChI=1S/2C53H34N4/c1-4-14-34(15-5-1)36-24-27-48-44(30-36)45-32-38(25-28-49(45)56(48)40-19-8-3-9-20-40)37-26-29-50-43(31-37)42-22-12-13-23-47(42)57(50)53-46-33-39-18-10-11-21-41(39)51(46)54-52(55-53)35-16-6-2-7-17-35;1-4-14-34(15-5-1)36-24-27-48-44(30-36)45-32-38(25-28-49(45)56(48)40-19-8-3-9-20-40)37-26-29-50-43(31-37)42-22-12-13-23-47(42)57(50)53-54-51(35-16-6-2-7-17-35)46-33-39-18-10-11-21-41(39)52(46)55-53/h2*1-32H,33H2.
What are the key properties of 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine?
2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine has a molecular weight of 1453.77 g/mol, XLogP of 26.49, 10 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-4-phenyl-5H-indeno[1,2-d]pyrimidine;4-[3-(6,9-diphenylcarbazol-3-yl)carbazol-9-yl]-2-phenyl-5H-indeno[1,2-d]pyrimidine is sourced from PubChem (CID 158005802), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).